| (Values in U.S. Thousands) | Jun, 2023 | Mar, 2023 | Dec, 2022 | Sep, 2022 | Jun, 2022 |
| Sales | 10,300 | 13,050 | 12,670 | 12,390 | 12,640 |
| Sales Growth | -21.07% | +3.00% | +2.26% | -1.98% | +9.91% |
| Net Income | -10,620 | -7,970 | -5,440 | -9,910 | -9,400 |
| Net Income Growth | -33.25% | -46.51% | +45.11% | -5.43% | -15.34% |
Aziyo Biologics Inc Cl A
(AZYO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Aziyo Biologics Inc.is a regenerative medicine company. It focuses on the development of regenerative medical products to address the implantable electronic device/cardiovascular, orthopedic/spinal repair, and soft tissue reconstruction markets. The company operates principally in Roswell, Georgia; and Richmond, California. Aziyo Biologics Inc.is based in Silver Spring, Maryland.